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DIVAContagious bovine pleuropneumonia (CBPP) is the most serious cattle disease in Africa, caused by
Mycoplasma mycoides subsp. mycoides small-colony type (SC). CBPP control strategies currently rely on
vaccination with a vaccine based on live attenuated strains of the organism. Recently, an lppQ−mutant of the
existing vaccine strain T1/44 has been developed (Janis et al., 2008). This T1lppQ−mutant strain is devoid of
lipoprotein LppQ, a potential virulence attribute of M. mycoides subsp. mycoides SC. It is designated as a
potential live DIVA (Differentiating Infected from Vaccinated Animals) vaccine strain allowing both
serological and etiological differentiation. The present paper reports on the validation of a control strategy
for CBPP in cattle, whereby a TaqMan real-time PCR based on the lppQ gene has been developed for the direct
detection of M. mycoides subsp. mycoides SC in ex vivo bronchoalveolar lavage ﬂuids of cows and for the
discrimination of wild type strains from the lppQ− mutant vaccine strain.+41 31 631 2634.
license. © 2010 Elsevier B.V. Open access under CC BY license. 1. Introduction
Contagious bovine pleuropneumonia (CBPP) caused byMycoplasma
mycoides subsp.mycoides small-colony type (SC), a bacteriumbelonging
to the classMollicutes, is amajor constraint to cattle production in areas
of eastern, central and western Africa, either as an endemic or re-
emerging disease or in epidemic form (Windsor, 2000; Miltiadou et al.,
2009). CBPP is currently considered one of themain stumbling blocks to
the growth of the livestock industry on the African continent. Yearly
losses directly or indirectly due to CBPP in Africa are estimated to be
around 2 billion US dollars (Food and Agriculture Organization of the
UnitedNations, 2004). Control of CBPP is therefore important asaway to
salvage the losses and to ensure cattle owners of an income(Tambi et al.,
2006). Current strategies to control CBPP rely on local quarantine of
affected herds, antibiotic treatment of clinically diseased animals, or
vaccination with a vaccine based on live attenuated strains.
Efﬁcient control of CBPP not only requires more efﬁcient vaccine
strains (Thiaucourt et al., 2000, 2003; Thiaucourt, 2002;Wesonga et al.,
2003; Mbulu et al., 2004; Pilo et al., 2007; Bischof et al., 2009), but also
reliable diagnostic strategies that allow differentiating infected from
vaccinated animals (DIVA). Lipoprotein LppQ is a particular membrane
located protein of M. mycoides subsp. mycoides SC as it is serologically
speciﬁc to this organism. It has a particularly strong antigenic N-
terminal part that is located on the outer surface of the membrane
(Bonvin-Klotz et al., 2008) and that elicits a speciﬁc and early immuneresponse in naturally and experimentally infected animals (Bruderer
et al., 2002). The C-terminal part of LppQ possesses an integral
membrane structure built up of repeated units that are suspected to
be involved in membrane anchoring (Abdo et al., 2000; Bonvin-Klotz
et al., 2008). A recent study has shown that cattle immunized with the
recombinant peptide comprising the extracellular N-terminal part of
LppQ, using different adjuvant methods, were signiﬁcantly more
susceptible to infection with a virulentM. mycoides subsp.mycoides SC
strain than cattle that were not vaccinated with LppQ (Nicholas et al.,
2004). Hence, LppQ — which is devoid of protective T-cell epitopes
(Dedieu et al., 2009)— appeared to exacerbate the effects of CBPP. Thus,
an attenuated mutant lacking lppQ is likely to be a valuable second-
generation vaccine and is expected to give lower side effects.
In the view to develop new efﬁcacious and safe vaccine strains, the
gene lppQwas inactivated by genetic engineering in the currently used
live vaccine strain T1/44 using a transposon-based approach (Janis et al.,
2008). In the present work, we aimed to develop a diagnostic tool for
detection of M. mycoides subsp. mycoides SC in the lungs of CBPP-
affected cattle andwhichallows discriminationofwild type strains from
the recombinant DIVA T1lppQ−mutant vaccine strain.
2. Materials and methods
2.1. Mycoplasma strains, growth conditions and DNA extraction
Strains of mycoplasmas (n=86) used in this study are listed in
Table 1. Cells were grown in a standard mycoplasma medium (Axcell
Biotechnologies, St. Genis l'Argentière, France) at 37 °C to a density of
Table 1
TaqMan results for the 86 strains of mycoplasmas tested in this study.
Species Straina Origin Isolated Host TaqMan
FTb MGBb
M. mycoides subsp. mycoides SC PG1 1931 Cattle/type strain + +
2059 Spain 1984 Cattle/lung + +
B773/125 Portugal 1991 Cattle/semen + +
C305 Portugal 1993 Goat/lung + +
O326 Portugal 1993 Sheep/milk + +
PO 1967 France 1967 Cattle/lung + +
PO 2 France 1980 Cattle/lung + +
2022 France 1984 Cattle/lung + +
L2 Italy 1993 Cattle/lung + +
402 Italy 1990 Cattle/lung + +
6479 Italy 1992 Cattle/lung + +
Afadé Cameroon 1968 Cattle/lung + +
87137-9 Burkina Faso 1987 Cattle + +
Filﬁli Senegal Pre-1988 Cattle + +
Fatick Senegal 1968 Cattle + +
B17 Chad 1967 Zebu + +
9050-529/1 Ivory Coast 1990 Cattle + +
91130 Central African Republic 1991 Cattle + +
94111 Rwanda 1994 Cattle + +
95014 Tanzania 1995 Cattle + +
T1/44 Tanzania 1952 Cattle/vaccine strain + +
T1lppQ−MT1 DIVA mutant 2008 Transposon-based random mutagenesis − +
T1lppQ−RSP1 Recombinant mutant 2008 Transposon-based random mutagenesis + +
T1/Sr50 Tanzania 1952 Cattle/vaccine strain + +
KH3J Sudan 1940 Cattle/vaccine strain + +
Gladysdale Australia Pre-1964 Cattle + +
DVZ Australia 1965 Cattle + +
R575 Australia 1965–1968 Cattle + +
V5 Australia 1936 Cattle/vaccine strain + +
Mycoplasma leachii PG50 Australia 1963 Cattle/joint/reference strain + −
B5415 Portugal Cattle + −
CP291 Portugal Goat/lung + −
PAD3186 India 1993 Goat/milk + −
FRD424 India 1993 Goat/milk + −
Calf 1 Nigeria Cattle/blood + −
D318b Germany Cattle/semen + −
C2306 Portugal Cattle + −
D424 Germany Cattle/preputium + −
QR1/92 Australia + −
4055 France Cattle/lung + −
B144P USA 1956 Cattle/joint + −
M. mycoides subsp. capri PG3 Turkey 1950 Goat/type strain − −
N108 Nigeria 1977 Goat − −
Capri L France 1975 Goat − −
9139/11-91 Turkey 1991 − −
WK354/80 Switzerland 1980 Goat − −
213 India 1984 Goat − −
Y-goat Australia 1956 Goat/type strain (serovar MmmLC) − −
152/93 Grand Canary 1993 Goat − −
LC8065 France Goat − −
D2482/91 Switzerland 1991 Goat − −
950010 France 1995 Goat − −
D2083/91 Switzerland 1991 Goat − −
CP271 Portugal 1991 Goat − −
D2503 Switzerland Goat − −
M. capricolum subsp. capricolum California kid USA 1955 Goat/type strain − −
173/87 Greece 1987 Sheep − −
6443.90 France 1990 Goat − −
M. capricolum subsp. capripneumoniae F38 Kenya 1976 Goat/type strain − −
9081-487p Oman 1990 Goat − −
Gabès Tunisia 1981 Goat − −
M. bovis PG45 USA 1962 Cattle/milk/type strain − −
ML1 France Pre-1999 Rabbit/lung − −
120/81 Germany 1980–1990 Cattle/milk − −
221/89 Germany 1980–1990 Cattle/milk − −
86p Belgium 1990–2000 Cattle/milk − −
39G Belgium 1990–2000 Cattle/bronchoalveolar lavage ﬂuid − −
0435 Belgium 1990–2000 Cattle/bronchoalveolar lavage ﬂuid − −
9585 Belgium 1990–2000 Cattle/bronchoalveolar lavage ﬂuid − −
2610 UK 1990–2000 Cattle/joint ﬂuid − −
2138 UK 1990–2000 Cattle/milk − −
2960 UK 1990–2000 Cattle/lung − −
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Table 1 (continued)
Species Straina Origin Isolated Host TaqMan
FTb MGBb
M. bovirhinis PG43 1967 Cattle/respiratory tract/type strain − −
O/D1467 Switzerland 2007 Cattle/bronchus − −
IMD1656 Switzerland 2008 Cattle/bronchus − −
M. bovigenitalium PG11 United Kingdom Cattle/type strain − −
2D Australia 1974 Sheep (former serogroup 11 strain) − −
M. bovoculi RF20391 Cattle − −
M. agalactiae PG2 Spain 1973 Goat/type strain − −
3990 France − −
5725 France 1990 Sheep − −
M. putrefaciens KS1 USA Goat/type strain − −
M. ovipneumoniae Y98 Sheep/respiratory tract/type strain − −
M. conjunctivae HRC/581 USA 1972 Sheep/type strain − −
M. hyopneumoniae J 1965 Swine/type strain − −
M. arginini G230 Mouse/brain/type strain − −
a Collections: the strains were obtained from the Australian Animal Health Laboratory (AAHL), Geelong, Victoria, Australia; Agence Française de Sécurité Sanitaire des Aliments
(AFSSA), Lyon, France; BGVV, Jena, Germany; CIRAD-EMVT, Montpellier, France; Faculdad de Veterinaria, Universidad de Las Palmas, Spain; INRA, Villenave d'Ornon, France; Institute
of Veterinary Bacteriology, University of Bern, Switzerland; Laboratório Nacional de Investigação Veterinária, Lisboa, Portugal; Laboratoire de Pathologie Bovine, Lyon, France;
National Collection of Type Cultures (NCTC), PHLS, London, UK; National Veterinary Institute, Uppsala, Sweden; and Faculty of Veterinary Medicine, University of Liège, Belgium.
b As determined in this study by real-time PCR of approximately 10 ng of genomic DNA. FT, TaqMan assay with the lppQ-based FAM probe (Bischof et al., 2006); MGB, TaqMan
assay with the lppQ-based minor groove binding probe (Vilei et al., 2007).
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Biotechnologies). Growth and handling of live M. mycoides subsp.
mycoides SC were performed in a biological safety laboratory fulﬁlling
the BL3 containment safety standards. Lysis of mycoplasmas with GES
buffer (5 M guanidium thiocyanate, 100 mM EDTA, 0.5%N-lauroylsarco-
sine) and extraction of genomic DNA were performed as previously
described (Vilei and Frey, 2001; Pilo et al., 2005; Bischof et al., 2008).
Disruption of lppQ in the vaccine T1/44was achieved by transposon-
based genetic engineering to obtain the mutants T1lppQ−MT1 and
T1lppQ−RSP1 (Janis et al., 2008) (Table 1).2.2. PCR and sequencing strategies
Polymerase chain reaction (PCR) was performed with a DNA
thermal cycler Gene Amp PCR System 9600 (Applied Biosystems,
Foster City, CA, USA) in a 30-μl reaction mixture [1× reaction buffer B
(supplied with FIREPol® DNA polymerase), 2.5 mM MgCl2, 250 μM of
each dNTP] that contained approximately 50 ng of genomic template
DNA, 2.5 U of FIREPol® DNA polymerase (Solis BioDyne, Tartu,
Estonia), and 400 nM of oligonucleotide primers MMMLP481 and
MMMLP484 (Abdo et al., 2000) for lppQ ampliﬁcation. The mixtures
were subjected to 3-min denaturation at 94 °C followed by 35 cycles
of ampliﬁcation with the parameters: 30 s at 94 °C, 30 s at 48 °C and
3 min extension at 72 °C, and a ﬁnal extension step at 72 °C for 7 min.
Amplicons were puriﬁed with the High pure PCR product puriﬁcation
kit (Roche Diagnostics, Rotkreuz, Switzerland).
DNA sequence analysis of the puriﬁed amplicons was performed
with a DNASequenator AB 3100 genetic analyzer and the Taq dye deoxy
terminator cycle sequencing kit (Applied Biosystems) using primers
MMMLP481 and MMMLP484 for lppQ (Table 2). The assembly of DNATable 2
Primers and probes used for TaqMan PCR assays deduced from the lppQ gene sequence of M
Primer Sequence (5′–3′)
lppQ-based TaqMan FT PCR (Bischof et al., 2006)
lppQTM-L AATAATCAACAAAAAAAAGAGCAAGTA
lppQTM-R TAGCCCTTTTATTTTTAGTAATGCTTGTA
lppQTM_FT ACATCTTGTTTTTGTCACTCATTTTTTGG
lppQ-based TaqMan MGB PCR (Vilei et al., 2007)
lppQTM2-L CTAGAACTGAGGTTTTAGTAATTGGTTA
lppQTM2-R CACGCTCTAGACTAATAATTTCTTCTGGT
lppQTM2-MGB AAAAATTTCTGGGTTTGCTCAA
a Based on nucleotide sequence NC_005364, the complete genome ofM. mycoides subsp.m
1165902–1167239 and nt 1189659–1190996. Note that lppQ occurs only in one copy in allsequences and alignments of sequenced segments were done using the
program Sequencher 4.6 (GeneCodes, Ann Arbor, MI, USA). Compar-
isons of DNA sequences and their deduced amino acid sequences with
theEMBL/GenBankdatabasewereperformedusing theBLASTprograms
blastn, blastx and blastp (Altschul et al., 1990).2.3. Selection of primers and TaqMan probes
Primer Express 2.0 software (Applied Biosystems) was used to
design oligonucleotide primers and ﬂuorogenic probe, to be used in a
TaqMan platform, speciﬁc to the locus of the gene lppQ of wild type
strains ofM. mycoides subsp.mycoides SC. The software displayed the
two primers lppQTM-L and lppQTM-R, and the probe lppQTM_FT
with FAM reporter dye and TAMRA quencher afﬁxed on the 5′ and 3′
ends, respectively (Table 2) (Bischof et al., 2006). This TaqMan FT
assay can discriminate wild type strains of M. mycoides subsp.
mycoides SC from the recombinant strain T1lppQ−MT1, as the FT
probe is concerned by the integration of the transposon after
nucleotide position 208 of the lppQ gene (Fig. 1). As strains of
Mycoplasma leachii — formerly known as Mycoplasma sp. bovine
group 7 (Manso-Silván et al., 2009)— harbour a DNA fragment that is
similar to lppQ (Fig. 1), real-time PCR using these oligonucleotides
also detected strains of M. leachii. Thus, in the optic to select lppQ-
speciﬁc TaqMan primers and probe that can discriminateM.mycoides
subsp. mycoides SC from M. leachii (as well as from all other
mycoplasmas), a new search was performed by using the TaqMan
MGB (minor groove binder) primer and probe design option of
Primer Express 2.0. MGB is a non-ﬂuorescent quencher and
substitutes TAMRA at the 3′ end of the probe. The sequence of the
employed 22-nt probe lppQTM2-MGB is indicated in Table 2. As. mycoides subsp. mycoides SC type strain PG1.
Positiona
AGTAA 1166019–1166050; 1189776–1189807
A 1166144–1166115; 1189901–1189872
TTCAATTTT 1166113–1166076; 1189870–1189833
TGA 1166317–1166347; 1190074–1190104
A 1166433–1166404; 1190190–1190161
1166357–1166378; 1190114–1190135
ycoides SC type strain PG1 (Westberg et al., 2004). The two copies of lppQ in PG1 span nt
other M. mycoides subsp. mycoides SC strains (Bischof et al., 2006).
Fig. 1. Locationof the TaqManprimersandprobeswithin the lppQgene. The sequence of the lppQgene fromtype strainPG1(where it ispresent in twocopies) ofM.mycoides subsp.mycoides
SCwas alignedwith the lppQpseudogenesequence from thereference strain PG50ofM. leachiiusing theprogramDIALIGN2.2.1 (http://bibiserv.techfak.uni-bielefeld.de/dialign/submission.
html), and the alignmentwas ﬁnally elaboratedwith Boxshade 3.21 (http://www.ch.embnet.org/software/BOX_form.html). Identical nucleotides are shown on black background. The grey
arrowheads indicate the site of disruption of lppQ in themutants T1lppQ−MT1,whichproduces only 69N-terminal amino acids of LppQ, andT1lppQ−RSP1,which still produces about 3/4 of
the LppQ polypeptide. Themutant strains were achieved by genetic engineering using a transposon-based approach for the randommutagenesis of vaccine strain T1/44 (Janis et al., 2008).
TaqMan primers are indicated by arrows, probes by lines.
214 E.M. Vilei, J. Frey / Journal of Microbiological Methods 81 (2010) 211–218already reported (Vilei et al., 2007), primers lppQTM2-L and
lppQTM2-R (Table 2) speciﬁcally amplify a 117-bp fragment from
the locus of the gene lppQ ofM.mycoides subsp.mycoides SC. All threeoligonucleotides of the TaqManMGB assay, however, matchwith the
disrupted lppQ of the DIVA recombinant strain T1lppQ−MT1 (Fig. 1)
and hence cannot discriminate the latter.
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Reactions were performed by using 2.5 µl of samples from each
strain or 2.5 µl of 10 min-boiled bronchoalveolar lavage ﬂuids, a
900 nM concentration of each TaqMan primer (Table 2) and 300 nM
TaqMan probe (Table 2), and TaqMan Universal PCR Master Mix No
AmpErase UNG (Applied Biosystems) in a 25-μl volume. An
exogenous Internal Positive Control (IPC) reagent, consisting of 0.5×
TaqMan IPC DNA, and 0.5× TaqMan IPC primers and probe (with VIC
reporter and TAMRA quencher) (Applied Biosystems), was spiked
into each reaction well of the TaqMan MGB assay in order to
distinguish true target negatives from PCR inhibition. The concentra-
tion of the IPC primers in the PCR reaction was set reasonably lower
than that of target primers, so that the ampliﬁcation efﬁciency of the
target reaction was not compromised. Real-time PCR reactions were
run on an ABI 7500 instrument (Applied Biosystems) using the
following cycling parameters: after one step at 50 °C for 2 min and at
95 °C for 10 min, 40 cycles of denaturation at 95 °C for 15 s and
extension at 60 °C for 1 min were performed. Real-time ﬂuorescence
measurements were taken for each sample by using the Sequence
Detector software 1.3.1 (Applied Biosystems) and the PCR cycle
number at which the ﬂuorescent lppQ-signal crossed the cycle
threshold limit for each sample (2.5 µl) was recorded as Ct value.
The threshold, i.e., the detected limit where the ﬁrst PCR cycle has a
signiﬁcant increase in ﬂuorescence signal, was adjusted at 0.1 for the
TaqMan FT assay and at 0.2 for the TaqMan MGB assay. In both cases,
thresholds were moved higher in the exponential phase of ampliﬁ-
cation than the default threshold values to avoid background noise.
The ﬂuorescence emission baseline was calculated from the ﬁrst 3 to
15 cycles. Each sample was assayed in duplicate (unless otherwise
stated), and the assay was repeated if the standard deviation (SD)
between the two replicates was greater than 1 Ct.2.5. Standard curves and speciﬁcity of the TaqMan assays
Three-day cultures (108–109 cells/ml, see above) of M. mycoides
subsp. mycoides SC strains C305 and 2022 (Table 1) were
centrifuged at 36,000×g for 30 min. The pellets were washed
once and then resuspended at a density of approximately
5×1010 cells/ml with the aid of a 27-gauge needle in sterile 0.85%
sodium chloride solution. Small aliquots of these mycoplasma
suspensions were used to count the number of colony forming
units CFU obtained from 10-fold serial dilutions on solid mycoplas-
ma medium (Axcell Biotechnologies). TaqMan standard curves were
produced by analyzing serial dilutions of the two strains in lysis
buffer (100 mM Tris–HCl, pH 8.5, 0.05% Tween 20, 0.24 mg/ml
proteinase K), which contained 1.5 to 1.5×107 CFU per reaction
(i.e., 600 to 6×109 CFU/ml). Samples were mixed for 1 min and
incubated for 60 min at 60 °C followed by incubation for 15 min at
95 °C to obtain the lysates as template for PCR reactions in
triplicates. The efﬁciency of the two described TaqMan reactions
was calculated considering the slope of their standard curves and
using the formula (10−1/slope).
The speciﬁcity of the TaqMan assays was evaluated by testing
approximately 10 ng of genomic DNA of each mycoplasma (n=86)
listed in Table 1, which covered the ﬁve members of the mycoides
cluster that contains M. mycoides subsp. mycoides SC, M. leachii,
M. mycoides subsp. capri— that now groups also strains of the serovar
M. mycoides subsp. mycoides large-colony type (LC) (Manso-Silván
et al., 2009) — Mycoplasma capricolum subsp. capricolum, and
M. capricolum subsp. capripneumoniae, as well as a range of other
species covering phylogenetically related species and representatives
of other animal species. DNA was quantiﬁed spectrophotometrically
and by visual comparison after gel electrophoresis and ethidium
bromide staining.2.6. Artiﬁcial contamination of bronchoalveolar lavage ﬂuid with
mycoplasmal preparations
Samples of bronchoalveolar lavages (Baselski and Wunderink,
1994; Miserez et al., 1997) from cattle were contaminated artiﬁcially
with four consecutively 10-fold diluted suspensions of M. mycoides
subsp. mycoides SC strains C305, O326 and 2022 (Table 1) to reach
2.8×106 to 2.8×109 CFU/ml. Quantiﬁcation using the M. mycoides
subsp. mycoides SC-speciﬁc TaqMan MGB assay was performed to
conﬁrm these CFU values and to assess the diagnostic efﬁcacy of
the lipoprotein gene lppQ-based real-time PCR for detection of
M. mycoides subsp. mycoides SC in bronchoalveolar lavage ﬂuids of
cows.
2.7. Nucleotide sequence accession numbers
The nucleotide sequence of the lppQ pseudogene from the reference
strain PG50 of M. leachii has been deposited under the EMBL/GenBank
accession number AM158959 (1276 nucleotides in length).
3. Results
3.1. Standard curve and detection limit of the TaqMan assays
The standard curves for lppQ ampliﬁcation (Ct values vs. log10(CFU))
generated by 10-fold serial dilutions of the two M. mycoides subsp.
mycoides SC strains C305 and 2022 in lysis buffer were linear over a
range of 7 log units, as illustrated by R2 values of 0.9996 (FT assay) and
0.9999 (MGB assay). The slopes were−3.6004 (FT assay; Fig. 2A) and
−3.6236 (MGB assay; Fig. 2B), and the efﬁciencies (10−1/slope) of the
TaqMan assays were therefore 1.8956 (FT assay) and 1.8879 (MGB
assay), both close to 2 (perfect PCR ampliﬁcation). The detection limit of
both TaqMan assays was at ∼15 CFU per reaction, corresponding to
∼6000 CFU/ml. The estimated quantities of mycoplasmal cells in
clinical samples (see below) were determined using the formulas
CFUreaction=2.1077×1012×e−0.63925 ×Ct (FT assay; Fig 2C) and
CFUreaction=1.3494×1012×e−0.63539×Ct (MGB assay; Fig 2D), gen-
erated by linear regressions of the standard curves.
3.2. The lppQ pseudogene in M. leachii
M. leachii revealed a pseudogene of lppQ (AM158959) with stop
codons in all three forward frames, ruling out the possibility of
having any lipoprotein production. It has a nucleotide similarity of
84% to the lppQ gene of M. mycoides subsp. mycoides SC, showing
totally 18 gaps (Fig. 1). The TaqMan MGB primers and probe
(Table 2) were selected from the available lppQ sequences from
strains of M. mycoides subsp. mycoides SC so that they do not anneal
to lppQ of M. leachii.
3.3. TaqMan speciﬁcities
The wild type strains of M. mycoides subsp. mycoides SC analyzed
(n=27) and the mutant vaccine T1lppQ−RSP1 gave positive signals
when 10 ng of genomic DNA were tested in the TaqMan FT assay,
yielding a mean Ct value of 19.51 (SD, 0.28). DNA of themutant vaccine
T1lppQ−MT1 remained negative in this TaqMan FT assay. However,
strains ofM. leachii (n=12) all gave positive signals (Table 1).
In order todifferentiate these latter fromM.mycoides subsp.mycoides
SC, the TaqManMGB assaywas used. AllM.mycoides subsp.mycoides SC
strains analyzed (n=29), including both mutants T1lppQ−MT1 and
T1lppQ−RSP1 carrying disrupted lppQ genes, gave speciﬁc signals when
10 ng of genomic DNAwere tested in this TaqManMGB assay, yielding a
mean Ct value of 18.92 (SD, 0.22). The wide range of otherMycoplasma
species (n=57) gave negative reactions by the TaqMan MGB assay
(Table 1).
Fig. 2. TaqMan PCR ampliﬁcation of serial 10-fold dilutions ofM. mycoides subsp.mycoides SC in lysis buffer. TaqMan FT (panel A) and MGB (panel B) standard curves generated by
the analysis of known amounts of cells (CFU) of strains C305 and 2022. Three data sets for each strain and each dilution were used to generate a common standard curve. Themean Ct
values are plotted against the log copy numbers of the standard dilutions. The linear regressions and the coefﬁcients of correlation R2 were calculated. TaqMan FT (panel C) andMGB
(panel D) standard curves for calculation of the amount of M. mycoides subsp. mycoides SC cells per reaction. The CFU in the reaction tube is plotted against the Ct values obtained
with the serial 10-fold dilutions ofM. mycoides subsp. mycoides SC. The obtained equation CFUreaction=1.3494×1012×e−0.63539×Ct of the TaqMan MGB assay was used to calculate
the load of mycoplasmas in artiﬁcially contaminated bronchoalveolar lavage ﬂuids.
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CFU counts
Linear curves obtained from the lppQ-based TaqMan MGB real-
time PCR of bronchoalveolar lavage ﬂuids contaminated artiﬁcially
with four 10-fold dilutions ofM.mycoides subsp.mycoides SC cultures
from strains C305, O326 and 2022 had R2 values of N0.999 (not
shown). The estimated quantities of mycoplasmal cells in the
suspensions were derived from the linear regression of the standard
curve of the M. mycoides subsp. mycoides SC-speciﬁc TaqMan MGB
assay (see above) and were found to be comparable to the known
amount of inoculated cells (CFU), with a maximal divergence ofTable 3
Comparison between TaqMan MGB assay-calculated mycoplasmal loads in artiﬁcially conta
Inoculateda
(CFUreaction)
C305 O326
Loadreactionb Δ(%)c Loadreactionb
7×106 5.52×106 (±3.72×105) −21.08 4.93×106 (±
7×105 5.94×105 (±3.47×104) −15.16 5.74×105 (±
7×104 6.19×104 (±5280) −11.64 6.41×104 (±
7×103 6524 (±1260) −6.80 6974 (±
a CFU counts present in 2.5 μl of bronchoalveolar lavage ﬂuids contaminated artiﬁcially w
b Mycoplasmal loads obtained by applying the formula loadreaction=1.3494×1012×e−0.6
subsp. mycoides SC-speciﬁc TaqMan MGB assay. Four data sets for each strain and each dilu
c Percent difference between calculated mycoplasma loads and inoculated CFU counts.approximately 30% only (Table 3). Using higher concentrations
(≥2.8×108 CFU/ml), the calculated mycoplasmal loads in the
suspensions were found to be moderately lower (−15% to −30%)
compared to the inoculated CFU counts, whereas they were only
slightly lower (0% to −15%) at mycoplasmal concentrations
≤2.8×107 CFU/ml.
4. Discussion
The high speciﬁcity and strong antigenicity of LppQ have been
already exploited for the development of a robust indirect ELISA test for
serological diagnosis and for epidemiological investigations of CBPPminated bronchoalveolar lavage ﬂuids and inoculated CFU counts.
2022
Δ(%)c Loadreactionb Δ(%)c
3.76×105) −29.61 5.23×106 (±8.94×105) −25.23
2.58×104) −18.07 5.57×105 (±1.03×105) −20.38
5180) −8.50 6.51×104 (±3801) −7.03
250.7) −0.37 6864 (±339.2) −1.94
ith 10-fold diluted suspensions of the three strains C305, O326 and 2022.
3539×Ct generated by the linear regression of the standard curve from the M. mycoides
tion were used.
217E.M. Vilei, J. Frey / Journal of Microbiological Methods 81 (2010) 211–218(Bruderer et al., 2002). This ELISA test is able to differentiate infected
cattle from cattle immunized with the M. mycoides subsp. mycoides SC
DIVA strain T1lppQ−MT1, as the latter produces no LppQ (Janis et al.,
2008). Also several DNA-based assays, which are less burdensome than
diagnostic methods based on immunological tests, have already been
developed for the efﬁcient detection ofM.mycoides subsp.mycoides SC:
these include Southern blotting (Frey et al., 1995; Vilei et al., 1999; Pilo
et al., 2003), conventional PCR tests (Bashiruddin et al., 1994; Dedieu
et al., 1994; Miserez et al., 1997; Bashiruddin et al., 1999; Persson et al.,
1999; Vilei et al., 2000; Vilei and Frey, 2004;Miles et al., 2006) and real-
time PCR assays (Gorton et al., 2005; Bischof et al., 2006, 2008; Vilei
et al., 2007; Fitzmaurice et al., 2008; Lorenzon et al., 2008).
The current study has evidenced that the real-time PCR assay
using primers lppQTM-L and lppQTM-R, and the probe lppQTM_FT
(Table 2) in the lppQ-based TaqMan FT assay (Bischof et al., 2006)
works in such a discriminatory way that the disrupted lppQ gene in
the LppQ− mutant vaccine T1lppQ−MT1 is not detected. However,
this TaqMan FT assay also recognizes strains ofM. leachii because the
latter harbour an lppQ pseudogene that is not expressed due to stop
codons in all three forward frames. On the other hand, the second
lppQ-based real-time PCR assay employed in this study, which uses
primers lppQTM2-L and lppQTM2-R, and the probe lppQTM2-MGB
(Table 2) in the TaqManMGB assay (Vilei et al., 2007)may be applied
to speciﬁcally monitorM. mycoides subsp.mycoides SC in the lungs of
cattle presenting CBPP symptoms. In fact, this TaqMan MGB assay
was able to detect all DNAs extracted from M. mycoides subsp.
mycoides SC strains while the wide range of related Mycoplasma
species, including M. leachii, gave no reactions. Another important
feature is the sensitivity of both lppQ-based TaqMan assays, whereby
as less as 6000mycoplasmal cells/ml can be detected efﬁciently.
While validating the reproducibility of the M. mycoides subsp.
mycoides SC-speciﬁc TaqMan MGB assay, the estimated quantities
of mycoplasmal cells in the artiﬁcially contaminated clinical samples
were comparable to the inoculated CFU counts, showing divergences
lower than 30%. Sensitivity and speciﬁcity of the test under ﬁeld
conditions (living animals) remain to be explored.
In conclusion, the two lipoprotein gene lppQ-based TaqMan real-
time PCR assays described in this paper constitute a rapid, speciﬁc
and sensitive test for the detection of M. mycoides subsp. mycoides
SC. The MGB assay is speciﬁcally designed to monitor efﬁciently the
mycoplasma in the bronchoalveolar lavage ﬂuids of cattle presenting
CBPP symptoms, while the FT assay will be applicable for future
differentiation of cattle infected with wild type strains of M.
mycoides subsp. mycoides SC from those immunized with the DIVA
vaccine, i.e., the T1lppQ−MT1 derivative of the classical T1/44
vaccine strain.
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